A Study of JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection
Clinical trial NCT04667104 · COMPLETED
Trial details
- NCT number
- NCT04667104
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2022-05-16
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.